| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 9.99% | 0% | $18.5M | $5.33M | 1.46M | +40.4% | BVF PARTNERS L P/IL | Sep 30, 2025 |
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | 0% | $17.6M | $3.71M | 1.39M | +26.7% | RA Capital Management, L.P. | Sep 30, 2025 |
| Nantahala Capital Management, LLC | 9.39% | +12% | $15.7M | $4.26M | 1.24M | +37.2% | Nantahala Capital Management, LLC | Sep 30, 2025 |
| Point72 Asset Management, L.P. | 8% | +52% | $13.4M | $5.91M | 1.05M | +79.1% | Point72 Asset Management, L.P. | Sep 30, 2025 |
| Affinity Asset Advisors, LLC | 7.65% | +47% | $12.8M | $5.79M | 1.01M | +82.7% | Affinity Healthcare Fund, LP | Sep 30, 2025 |
| ORBIMED ADVISORS LLC | 8.9% | $9.55M | 967K | OrbiMed Advisors LLC | Jun 30, 2025 | |||
| Caligan Partners LP | 6.3% | $10.6M | 833K | Caligan Partners LP | Sep 30, 2025 | |||
| BALYASNY ASSET MANAGEMENT L.P. | 6.22% | $10.4M | 817K | Balyasny Asset Management L.P. | Sep 30, 2025 | |||
| SILVERARC CAPITAL MANAGEMENT, LLC | 5.48% | $9.16M | 721K | SilverArc Capital Management, LLC | Sep 30, 2025 | |||
| Ikarian Capital, LLC | 3.8% | -61.9% | $9.05M | -$6.1M | 712K | -40.3% | Ikarian Capital, LLC | Sep 30, 2025 |
| VANGUARD GROUP INC | 5.26% | $8.8M | 693K | The Vanguard Group | Sep 30, 2025 | |||
| Crutcher Patrick J | 4.2% | $5.43M | 549K | Patrick J. Crutcher | Aug 6, 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 15.3M | $195M | +$95.1M | $12.71 | 65 |
| 2025 Q2 | 7.84M | $39.1M | -$2.09M | $4.99 | 35 |
| 2025 Q1 | 8.26M | $66.1M | +$5.78M | $8.01 | 33 |
| 2024 Q4 | 7.53M | $56M | +$4.83M | $7.43 | 33 |
| 2024 Q3 | 6.66M | $63.2M | +$55.9M | $9.50 | 28 |
| 2024 Q2 | 771K | $9.62M | +$7.42M | $12.47 | 21 |
| 2024 Q1 | 701 | $9.89K | +$1.99K | $21.74 | 4 |
| 2023 Q4 | 23K | $209K | +$209K | $9.00 | 12 |